Aptose Biosciences Stock Forecast NASDAQ:APTO

Price Target and Analyst Ratings

Most Recent Rating

Piper Sandler is very positive about APTO and gave it a "Overweight" rating on July 05, 2021. The price target was changed from $12.00 to $7.00.

Last 30 Days

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-07-05	Overweight	Target Lowered by	Piper Sandler	$3.34	$12.00 → $7.00
2021-03-30	Outperform	Target Raised by	Oppenheimer	$6.22	$8.00 → $9.00
2021-03-24	Outperform	Target Raised by	Oppenheimer	$6.10	$8.00 → $9.00
2021-02-22	Buy	Initiated by	Jonestrading	$4.30	$14.00
2020-10-20	Buy	Reiterated by	Canaccord Genuity	$5.65	$13.00
2020-10-19	Overweight	Initiated by	Cantor Fitzgerald	$5.71	$10.00
2020-10-19	Overweight	Initiated by	Cantor Fitzgerald	$5.71
2020-09-22	Buy	Initiated by	Alliance Global Partners	$6.25	$12.00
2020-06-23	Overweight	Reiterated by	Piper Sandler	$6.90	$10.00
2020-06-14	Buy	Initiated by	Oppenheimer	$6.73	$9.00
2020-06-12	Buy	Reiterated by	HC Wainwright	$6.73	$9.00
2020-04-27	Buy	Reiterated by	HC Wainwright	$7.34	$9.00

APTO Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -17.13% during the next 3 months and, with a 90% probability hold a price between $1.78 and $2.48 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-20	$2.14	$2.56	$2.98
2021-09-21	$2.13	$2.55	$2.97
2021-09-22	$2.12	$2.54	$2.96
2021-09-23	$2.11	$2.53	$2.95
2021-09-24	$2.10	$2.52	$2.94
2021-09-27	$2.09	$2.51	$2.93
2021-09-28	$2.09	$2.50	$2.92
2021-09-29	$2.08	$2.49	$2.91
2021-09-30	$2.07	$2.48	$2.90
2021-10-01	$2.06	$2.47	$2.89
2021-10-04	$2.05	$2.46	$2.88
2021-10-05	$2.04	$2.46	$2.87
2021-10-06	$2.03	$2.45	$2.86
2021-10-07	$2.02	$2.44	$2.85
2021-10-08	$2.01	$2.43	$2.84
2021-10-11	$2.00	$2.42	$2.83
2021-10-12	$1.99	$2.41	$2.83
2021-10-13	$1.98	$2.40	$2.82
2021-10-14	$1.97	$2.39	$2.81
2021-10-15	$1.96	$2.38	$2.80
2021-10-18	$1.95	$2.37	$2.79
2021-10-19	$1.94	$2.36	$2.78
2021-10-20	$1.93	$2.35	$2.77
2021-10-21	$1.92	$2.34	$2.76
2021-10-22	$1.91	$2.33	$2.75
2021-10-25	$1.90	$2.32	$2.74
2021-10-26	$1.89	$2.31	$2.73
2021-10-27	$1.88	$2.30	$2.72
2021-10-28	$1.87	$2.29	$2.71
2021-10-29	$1.86	$2.28	$2.70

About Aptose Biosciences

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, a small molecule that induces the transcription of the Krüppel-like factor 4 Gene in in vitro studies and in in vivo pharmacodynamic studies of human xenograft tumors in mice. The companys APTO-253 clinical program has completed Phase-I clinic... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!